38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Mitomycin 20 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Mitomycin 20 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Fludarabine phosphate 50 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Fludarabine phosphate 50 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Chlorpromazine hydrochloride 5 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Ifosfamide 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ifosfamide 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Ifosfamide 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
pantoprazole 40 mg, fiole de poudre pour injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
pantoprazole 40 mg, fiole de poudre pour injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Ifosfamide 2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ifosfamide 2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Liothyronine sodium 20 microgram powder for solution for injection ampule	Count of base of active ingredient	False	un	Inferred relationship	Some
Liothyronine sodium 20 microgram powder for solution for injection ampule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Leuprorelin acetate 11.25 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Leuprorelin acetate 11.25 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Leuprorelin acetate 3.75 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Leuprorelin acetate 3.75 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Palivizumab 50 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Palivizumab 50 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Treosulfan 5 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Treosulfan 5 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely nabumetone 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
méropenem 1 g, fiole de poudre pour solution injectable	Count of base of active ingredient	False	un	Inferred relationship	Some
méropenem 1 g, fiole de poudre pour solution injectable	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
méropenem 1 g, fiole de poudre pour solution injectable	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vinblastine sulfate 10 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Vinblastine sulfate 10 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Sodium valproate 400 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Sodium valproate 400 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Prednisolone 3 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pentamidine isetionate 300 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pentamidine isetionate 300 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1

Start Previous Page 70 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module